ZURZUVAE

Drug Sage Therapeutics, Inc.
Total Payments
$5.4M
Transactions
14,827
Doctors
7,921
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $5.4M 14,827 7,921

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $4.7M 63 86.8%
Food and Beverage $327,227 14,492 6.1%
Consulting Fee $220,581 79 4.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $130,636 51 2.4%
Travel and Lodging $24,939 117 0.5%
Grant $3,000 1 0.1%
Education $491.36 24 0.0%

Payments by Type

Research
$4.7M
63 transactions
General
$706,874
14,764 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment with SAGE-217 in Adult Subjects with Major Depressive Disorder Sage Therapeutics, Inc. $4.5M 0
217-CLP-118 Sage Therapeutics, Inc. $159,624 0
A Comparative Study of Sage-217 Plus Sertraline Versus Placebo Plus Sertraline in Adults With Major Depressive Disorder Sage Therapeutics, Inc. $3,750 0

Top Doctors Receiving Payments for ZURZUVAE

Doctor Specialty Location Total Records
Madonna Ladouceur Commerce Township, MI $4.7M 77
, MD, MPH, PA Obstetrics & Gynecology League City, TX $44,415 34
, PMHNP-BC Registered Nurse Alachua, FL $27,151 39
, MD Psychiatry Monsey, NY $25,979 27
Elizabeth Cleveland Nurse Practitioner Evansville, IN $18,580 44
, MD Psychiatry Mason, OH $17,077 17
, MD Obstetrics & Gynecology Miami, FL $16,466 28
, M.D Student in an Organized Health Care Education/Training Program Thomaston, GA $14,395 9
, M.D Obstetrics & Gynecology Springfield, OR $12,834 9
, M.D Obstetrics & Gynecology New Orleans, LA $12,493 12
, M.D Obstetrics & Gynecology Fort Campbell, KY $11,666 10
, M.D Psychiatry Saint Charles, MO $11,050 4
, M.D Psychiatry Paterson, NJ $10,000 1
, MD Psychiatry Tampa, FL $9,168 6
, M.D Psychiatry Bethesda, MD $8,739 9
, M.D Obstetrics & Gynecology San Tan Valley, AZ $7,630 7
, MD Psychiatry San Diego, CA $7,537 5
, MD Neurology Boston, MA $7,500 1
, MD Obstetrics & Gynecology Chattanooga, TN $7,425 19
, M.D Psychiatry Costa Mesa, CA $6,452 2
, APRN, PMHNP- BC Psychiatric/Mental Health Wheeling, WV $6,369 4
, DRNP, APRN Registered Nurse Sewell, NJ $5,624 9
, DNP, APN-C Women's Health Philadelphia, PA $5,021 4
, MD Psychiatry Raleigh, NC $5,008 4
, M.D Psychiatry Los Angeles, CA $4,663 4

About ZURZUVAE

ZURZUVAE is a drug associated with $5.4M in payments to 7,921 healthcare providers, recorded across 14,827 transactions in the CMS Open Payments database. The primary manufacturer is Sage Therapeutics, Inc..

Payment data is available from 2024 to 2024. In 2024, $5.4M was paid across 14,827 transactions to 7,921 doctors.

The most common payment nature for ZURZUVAE is "Unspecified" ($4.7M, 86.8% of total).

ZURZUVAE is associated with 3 research studies, including "A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment with SAGE-217 in Adult Subjects with Major Depressive Disorder" ($4.5M).